Robert S. de Jong

Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial

Miriam Koopman, Ninja Antonini, Joep Douma et al. · The Lancet · 2007 · 631 citations

Medicine, Oncology, Pharmacology +12

Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study

Ciska Buijs, Constantijne H. Mom, Pax H.B. Willemse et al. · Breast Cancer Research and Treatment · 2008 · 91 citations

Pharmacy, Pharmacology, Pharmacotherapy +5

Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin

Robert S. de Jong, Nanno H. Mulder, Donald R. A. Uges et al. · British Journal of Cancer · 1999 · 55 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colorectal Cancer Group (DCCG) phase III study

Miriam Koopman, Ninja Antonini, J. Douma et al. · Annals of Oncology · 2006 · 39 citations · Full text

Medicine, Oncology, Pharmacology +16

Randomised Phase III study of biweekly 24-h infusion of high-dose 5FU with folinic acid and oxaliplatin versus monthly plus 5-FU/folinic acid in first-line treatment of advanced colorectal cancer

Geke A.P. Hospers, Michael Schaapveld, J.W.R. Nortier et al. · Annals of Oncology · 2006 · 37 citations

Medicine, Oncology, Pharmacotherapy +9